Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bali Pulendran

Showing results (241-250 of 262) with videos related to

Pageof 27
Sort By:
Science Translational Medicine|August 17, 2022
Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccinePrabhu S Arunachalam, Yupeng Feng, Usama Ashraf, et al.
Ebiomedicine|November 2, 2023
Corrigendum to "Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study" [eBioMedicine 83 (2022) 104208]Al Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
Ebiomedicine|August 11, 2022
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC studyAl Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
Research Square|June 30, 2025
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory BenefitCharles Langelier, Abigail Glascock, Cole Maguire, et al.
Cell|October 7, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Alexandra Schäfer, et al.
The Journal of Allergy and Clinical Immunology. Global|July 25, 2025
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohortNaresh Doni Jayavelu, Jingjing Qi, Carly E Milliren, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Science Immunology|August 30, 2024
Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding siteTom G Caniels, Max Medina-Ramìrez, Shiyu Zhang, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Identification of a multi-omics factor predictive of long COVID in the IMPACC studyGisela Gabernet, Jessica Maciuch, Jeremy P Gygi, et al.
JCI Insight|July 3, 2025
MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injuryHarry Pickering, Narges Alipanah-Lechner, Ernie Chen, et al.
Pageof 27

Showing results (241-250 of 262) with videos related to

Sort By:
Pageof 27
Science Translational Medicine|August 17, 2022
Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccinePrabhu S Arunachalam, Yupeng Feng, Usama Ashraf, et al.
Ebiomedicine|November 2, 2023
Corrigendum to "Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study" [eBioMedicine 83 (2022) 104208]Al Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
Ebiomedicine|August 11, 2022
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC studyAl Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
Research Square|June 30, 2025
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory BenefitCharles Langelier, Abigail Glascock, Cole Maguire, et al.
Cell|October 7, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Alexandra Schäfer, et al.
The Journal of Allergy and Clinical Immunology. Global|July 25, 2025
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohortNaresh Doni Jayavelu, Jingjing Qi, Carly E Milliren, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Science Immunology|August 30, 2024
Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding siteTom G Caniels, Max Medina-Ramìrez, Shiyu Zhang, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Identification of a multi-omics factor predictive of long COVID in the IMPACC studyGisela Gabernet, Jessica Maciuch, Jeremy P Gygi, et al.
JCI Insight|July 3, 2025
MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injuryHarry Pickering, Narges Alipanah-Lechner, Ernie Chen, et al.
Pageof 27